Symbicort Related Published Studies
Well-designed clinical trials related to Symbicort (Budesonide Inhalation)
Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids. [2008.09]
Effectiveness of high repeated doses of inhaled budesonide or fluticasone in controlling acute asthma exacerbations in young children. [2008.09]
[Efficacy and safety of budesonide inhalation suspension nebulization by mesh nebulizer in Japanese infants and young children with bronchial asthma in 12-week, randomised, open study] [2008.08]
Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. [2008.05]
Relative systemic availability of budesonide in patients with asthma after inhalation from two dry powder inhalers. [2008.05]
The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. [2008.05]
Long-term effects of budesonide on inflammatory status in COPD. [2008.04]
Bronchodilation of formoterol administered with budesonide: Device and formulation effects. [2008.03]
Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help? [2008.01]
Efficacy and safety of a new pressurised metered-dose inhaler formulation of budesonide/formoterol in children with asthma: a superiority and therapeutic equivalence study. [2008]
Safety of inhaled budesonide: clinical manifestations of systemic corticosteroid-related adverse effects. [2008]
Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma. [2007.11]
Plasma concentrations of fluticasone propionate and budesonide following inhalation: effect of induced bronchoconstriction. [2007.10]
Montelukast vs. Inhaled Low-Dose Budesonide as Monotherapy in the Treatment of Mild Persistent Asthma: A Randomized Double Blind Controlled Trial. [2007.10]
Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction. [2007.09]
Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma. [2007.08]
The oral, once-daily phosphodiesterase 4 inhibitor roflumilast lacks relevant pharmacokinetic interactions with inhaled budesonide. [2007.08]
Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control. [2007.08]
Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life. [2007.07.04]
A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler. [2007.06]
Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. [2007.05]
Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma. [2007.04]
Potency ratio fluticasone propionate (Flixotide Diskus)/budesonide (Pulmicort Turbuhaler). [2007.03]
The effects of inhaled budesonide and formoterol in combination and alone when given directly after allergen challenge. [2007.02]
Once versus twice daily budesonide metered-dose inhaler in children with mild to moderate asthma: effect on symptoms and bronchial responsiveness. [2007.01]
Ciclesonide is more effective than budesonide in the treatment of persistent asthma. [2007]
Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study. [2006.12.04]
Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. [2006.12]
Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma. [2006.12]
Effectiveness of early budesonide intervention in Caucasian versus Asian patients with asthma: 3-year results of the START study. [2006.11]
Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: A SOMA study. [2006.10]
Budesonide/formoterol improves lung function compared with budesonide alone in children with asthma. [2006.09]
Treatment with 400 microg of inhaled budesonide vs 200 microg of inhaled budesonide and oral montelukast in children with moderate persistent asthma: randomized controlled trial. [2006.09]
Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. [2006.08.26]
Pharmacoscintigraphic evaluation of lipid dry powder budesonide formulations for inhalation. [2006.08]
EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma. [2006.07]
Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflation. [2006.07]
Emitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmatics. [2006.06.19]
A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma. [2006.06]
Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. [2006.06]
Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study. [2006.05]
Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma. [2006.05]
Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma. [2006.05]
Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study. [2006.05]
Safety and tolerability of inhaled budesonide in children in the Steroid Treatment As Regular Therapy in early asthma (START) trial. [2006.05]
Activity of budesonide on nasal neutrophilic inflammation and obstruction in children with recurrent upper airway infections. A preliminary investigation. [2006.03]
Adjustable maintenance dosing with budesonide/formoterol or budesonide: double-blind study. [2006.03]
Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. [2006.02]
Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPD. [2006.02]
Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol. [2006.01.24]
The 24 h duration of bronchodilator action of the budesonide/formoterol combination inhaler. [2006.01]
Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. [2006]
Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma. [2006]
Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. [2006]
Clinical effectiveness of nebulised budesonide in the treatment of acute asthma attacks. [2006]
Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study. [2005.11]
Patient satisfaction with budesonide Turbuhaler versus triamcinolone acetonide administered via pressurized metered-dose inhaler in a managed care setting. [2005.11]
The effect of nebulized budesonide treatment in children with mild to moderate exacerbations of asthma. [2005.10]
Efficacy and tolerability of budesonide Clickhaler and Turbuhaler in adult asthma. [2005.10]
Formoterol added to low-dose budesonide has no additional antiinflammatory effect in asthmatic patients. [2005.09]
A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide. [2005.07]
Tapering dose of inhaled budesonide in subjects with mild-to-moderate persistent asthma treated with montelukast: a 16-week single-blind randomized study. [2005.06]
Dose-response comparison of budesonide dry powder inhalers using adenosine monophosphate bronchial challenge. [2005.06]
Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers. [2005.06]
Budesonide offers no advantage when added to oral dexamethasone in the treatment of croup. [2005.06]
Improvement of asthma control with beclomethasone extrafine aerosol compared to fluticasone and budesonide. [2005.06]
Effects of inhaled corticosteroids on growth in asthmatic children: a comparison of fluticasone propionate with budesonide. [2005.05]
Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects. [2005.05]
The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma. [2005.04]
Study on serum and urinary cortisol levels of asthmatic patients after treatment with high dose inhaled beclomethasone dipropionate or budesonide. [2005.04]
Comparison of the efficacy of inhaled budesonide and oral choline in patients with allergic rhinitis. [2005.03]
[The long term effect of small dose budesonide turbuhaler on mild bronchial asthma] [2005.02]
Equivalent lung deposition of budesonide in vivo: a comparison of dry powder inhalers using a pharmacokinetic method. [2005.02]
Long-term safety of once-daily budesonide in patients with early-onset mild persistent asthma: results of the Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) study. [2005.01]
Safety of budesonide inhalation suspension in infants aged six to twelve months with mild to moderate persistent asthma or recurrent wheeze. [2005.01]
Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthma. [2005]
Acute effect of nebulized budesonide in asthmatic children. [2005]
The effect of montelukast and different doses of budesonide on IgE serum levels and clinical parameters in children with newly diagnosed asthma. [2005]
A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium. [2004.10.01]
An economic evaluation of adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study. [2004.10]
Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. [2004.09]
The effect of adjustable dosing with budesonide/formoterol on health-related quality of life and asthma control compared with fixed dosing. [2004.08]
Safety profile of budesonide inhalation suspension in the pediatric population: worldwide experience. [2004.07]
Long-term effect of budesonide on hypothalamic-pituitary-adrenal axis function in children with mild to moderate asthma. [2004.06]
Adjustable and fixed dosing with budesonide/ formoterol via a single inhaler in asthma patients: the ASSURE study. [2004.05]
Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) improves health-related quality of life in adults previously receiving inhaled corticosteroids. [2004.01]
Effectiveness of budesonide administered via dry-powder inhaler versus triamcinolone acetonide administered via pressurized metered-dose inhaler for adults with persistent asthma in managed care settings. [2004.01]
Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide. [2004.01]
Adjustable maintenance dosing with budesonide/formoterol in a single inhaler provides effective asthma symptom control at a lower dose than fixed maintenance dosing. [2004]
Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction. [2004]
Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma. [2004]
Onset of action of formoterol/budesonide in single inhaler vs. formoterol in patients with COPD. [2004]
Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. [2003.12]
Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study. [2003.11]
Efficacy and safety of inhaled budesonide delivered once or twice daily via HFA-134a in mild to moderate persistent asthma in adult patients. Comparison with budesonide CFC. [2003.11]
Equivalent asthma control and systemic safety of inhaled budesonide delivered via HFA-134a or CFC propellant in a broad range of doses. [2003.11]
Budesonide/formoterol in a single inhaler (Symbicort) reduces healthcare costs compared with separate inhalers in the treatment of asthma over 12 months. [2003.10]
Budesonide/formoterol adjustable maintenance dosing reduces asthma exacerbations versus fixed dosing. [2003.10]
Effect of high starting dose of budesonide inhalation suspension on serum cortisol concentration in young children with recurrent wheezing episodes. [2003.09]
Comparisons of the complementary effect on exhaled nitric oxide of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide. [2003.09]
Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma. [2003.09]
|
